GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Book Value per Share

Hainan Poly Pharm Co (SZSE:300630) Book Value per Share : ¥7.00 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Book Value per Share?

Hainan Poly Pharm Co's book value per share for the quarter that ended in Sep. 2023 was ¥7.00.

During the past 12 months, Hainan Poly Pharm Co's average Book Value Per Share Growth Rate was 6.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 33.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 33.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Hainan Poly Pharm Co was 40.90% per year. The lowest was 9.40% per year. And the median was 36.00% per year.

Hainan Poly Pharm Co's current price is ¥12.35. Its book value per share for the quarter that ended in Sep. 2023 was ¥7.00. Hence, today's PB Ratio of Hainan Poly Pharm Co is 1.76.

During the past 11 years, the highest P/B Ratio of Hainan Poly Pharm Co was 18.85. The lowest was 1.76. And the median was 9.10.

Good Sign:

Hainan Poly Pharm Co Ltd stock PB Ratio (=1.76) is close to 10-year low of 1.76


Hainan Poly Pharm Co Book Value per Share Historical Data

The historical data trend for Hainan Poly Pharm Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Book Value per Share Chart

Hainan Poly Pharm Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.10 2.72 4.67 5.82 6.42

Hainan Poly Pharm Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.56 6.42 6.74 6.91 7.00

Competitive Comparison of Hainan Poly Pharm Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Poly Pharm Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's PB Ratio falls into.



Hainan Poly Pharm Co Book Value per Share Calculation

Hainan Poly Pharm Co's Book Value Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2,803-0)/436
=6.42

Hainan Poly Pharm Co's Book Value Per Share for the quarter that ended in Sep. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(3,142-0)/449
=7.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Hainan Poly Pharm Co  (SZSE:300630) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Hainan Poly Pharm Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Poly Pharm Co (SZSE:300630) Business Description

Traded in Other Exchanges
N/A
Address
No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051
Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.
Executives
Fan De Zhu Independent director
Xie Hui Fang Supervisors
Pu Jian Executives
Xu Zhao Securities Affairs Representative
Shen Shi Hua Executives
Zhou Mao Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines